What we are studying
The purpose of this study is to see whether treatment with everolimus plus hormone treatment
after chemotherapy will increase the time without your cancer returning. The current standard
treatment after chemotherapy is hormone treatment alone. Everolimus is a drug currently
approved for the treatment of patients with advanced or metastatic kidney or breast cancer. It is
considered investigational for non-metastatic breast cancer patients. In this study you will get
hormone treatment with either everolimus or with placebo (a pill with no medication). The
combination of hormone-treatment and everolimus is experimental in patients with breast cancer.